drugset / Trial / NCT07061847
Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to evaluate the effectiveness of a new treatment in improving chronic migraine symptoms. This treatment involves a targeted lidocaine infusion into blood vessels in the skull to numb pain receptors, potentially leading to improvements in chronic migraine intensity, frequency, and duration.
Timeline
- Start
- 2025-03-10
- Primary completion
- 2027-03-10
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 1 % | Other |